Cosmax Toekomstige groei

Future criteriumcontroles 4/6

Cosmax zal naar verwachting groeien in winst en omzet met respectievelijk 27.6% en 12.7% per jaar. De winst per aandeel zal naar verwachting groeien met 27.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 24.3% zijn.

Belangrijke informatie

27.6%

Groei van de winst

27.6%

Groei van de winst per aandeel

Personal Products winstgroei11.8%
Inkomstengroei12.7%
Toekomstig rendement op eigen vermogen24.3%
Dekking van analisten

Good

Laatst bijgewerkt29 Oct 2024

Recente toekomstige groei-updates

Recent updates

There's Been No Shortage Of Growth Recently For Cosmax's (KRX:192820) Returns On Capital

Sep 13
There's Been No Shortage Of Growth Recently For Cosmax's (KRX:192820) Returns On Capital

Cosmax, Inc. (KRX:192820) Stocks Pounded By 32% But Not Lagging Market On Growth Or Pricing

Aug 07
Cosmax, Inc. (KRX:192820) Stocks Pounded By 32% But Not Lagging Market On Growth Or Pricing

Cosmax, Inc. (KRX:192820) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jul 19
Cosmax, Inc. (KRX:192820) Shares Could Be 43% Below Their Intrinsic Value Estimate

Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?

Jun 18
Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) 28% Share Price Surge

May 21
Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) 28% Share Price Surge

We Like These Underlying Return On Capital Trends At Cosmax (KRX:192820)

Apr 18
We Like These Underlying Return On Capital Trends At Cosmax (KRX:192820)

Statutory Profit Doesn't Reflect How Good Cosmax's (KRX:192820) Earnings Are

Mar 27
Statutory Profit Doesn't Reflect How Good Cosmax's (KRX:192820) Earnings Are

Cosmax, Inc.'s (KRX:192820) Share Price Matching Investor Opinion

Mar 20
Cosmax, Inc.'s (KRX:192820) Share Price Matching Investor Opinion

We Think Cosmax (KRX:192820) Is Taking Some Risk With Its Debt

Feb 29
We Think Cosmax (KRX:192820) Is Taking Some Risk With Its Debt

Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?

Apr 16
Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?

Investors Can Find Comfort In Cosmax's (KRX:192820) Earnings Quality

Mar 25
Investors Can Find Comfort In Cosmax's (KRX:192820) Earnings Quality

Will Cosmax (KRX:192820) Multiply In Value Going Forward?

Mar 10
Will Cosmax (KRX:192820) Multiply In Value Going Forward?

What Type Of Shareholders Make Up Cosmax, Inc.'s (KRX:192820) Share Registry?

Feb 23
What Type Of Shareholders Make Up Cosmax, Inc.'s (KRX:192820) Share Registry?

Is It Worth Buying Cosmax, Inc. (KRX:192820) For Its 0.8% Dividend Yield?

Feb 08
Is It Worth Buying Cosmax, Inc. (KRX:192820) For Its 0.8% Dividend Yield?

Cosmax (KRX:192820) Share Prices Have Dropped 41% In The Last Five Years

Jan 22
Cosmax (KRX:192820) Share Prices Have Dropped 41% In The Last Five Years

Boasting A 6.1% Return On Equity, Is Cosmax, Inc. (KRX:192820) A Top Quality Stock?

Jan 07
Boasting A 6.1% Return On Equity, Is Cosmax, Inc. (KRX:192820) A Top Quality Stock?

There's A Lot To Like About Cosmax's (KRX:192820) Upcoming ₩900 Dividend

Dec 25
There's A Lot To Like About Cosmax's (KRX:192820) Upcoming ₩900 Dividend

Here's Why Cosmax (KRX:192820) Has A Meaningful Debt Burden

Dec 14
Here's Why Cosmax (KRX:192820) Has A Meaningful Debt Burden

We're Watching These Trends At Cosmax (KRX:192820)

Dec 01
We're Watching These Trends At Cosmax (KRX:192820)

Winst- en omzetgroeiprognoses

KOSE:A192820 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (KRW Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20262,702,852154,836152,976215,66416
12/31/20252,425,625134,141112,956182,89418
12/31/20242,126,418102,94051,292139,42717
6/30/20241,973,22372,86269,481196,158N/A
3/31/20241,901,03669,67291,250184,499N/A
12/31/20231,777,49457,137140,954231,021N/A
9/30/20231,741,27435,14782,887160,859N/A
6/30/20231,679,78431,22651,988153,723N/A
3/31/20231,605,53412,26841,231135,594N/A
12/31/20221,600,12620,84818,270102,531N/A
9/30/20221,620,85953,27576572,042N/A
6/30/20221,619,03653,13355,58995,319N/A
3/31/20221,644,37773,65449,17890,445N/A
12/31/20211,591,48874,43657,938100,046N/A
9/30/20211,524,74549,73215,70368,883N/A
6/30/20211,450,48844,39045,54097,307N/A
3/31/20211,399,35032,64033,99593,000N/A
12/31/20201,382,88121,378-18,44641,460N/A
9/30/20201,381,48340,5951,22562,103N/A
6/30/20201,378,24038,552-111,927-1,305N/A
3/31/20201,331,33127,621-89,59217,305N/A
12/31/20191,330,65331,823-31,17774,567N/A
9/30/20191,306,41928,290-93,1225,681N/A
6/30/20191,303,60929,761-21,50730,008N/A
3/31/20191,298,82932,302-53,435-318N/A
12/31/20181,259,71732,621-105,967-54,592N/A
9/30/20181,154,88928,078-159,175-30,777N/A
6/30/20181,048,77526,092-164,135-36,262N/A
3/31/2018953,54324,759N/A-16,433N/A
12/31/2017883,95018,855N/A-6,617N/A
9/30/2017859,62124,785N/A12,527N/A
6/30/2017837,21328,191N/A10,850N/A
3/31/2017802,62228,894N/A15,353N/A
12/31/2016756,96434,782N/A23,469N/A
9/30/2016701,78128,311N/A22,797N/A
6/30/2016640,40227,328N/A18,506N/A
3/31/2016590,43726,166N/A-11,262N/A
12/31/2015533,34321,244N/A-6,503N/A
9/30/2015565,34625,940N/A-13,870N/A
6/30/2015531,87323,923N/A-14,161N/A
3/31/2015486,71921,128N/A8,243N/A
12/31/2014403,47619,927N/A1,404N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei A192820 ( 27.6% per jaar) ligt boven de spaarquote ( 2.6% ).

Winst versus markt: De winst van A192820 ( 27.6% per jaar) zal naar verwachting langzamer groeien dan de markt KR ( 29.6% per jaar).

Hoge groeiwinsten: De winst van A192820 zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van A192820 ( 12.7% per jaar) zal naar verwachting sneller groeien dan de markt KR ( 9.9% per jaar).

Hoge groei-inkomsten: De omzet van A192820 ( 12.7% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen A192820 zal naar verwachting over 3 jaar hoog zijn ( 24.3 %)


Ontdek groeibedrijven